Most recently, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to some big range of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger and doesn't https://cassw406dhv7.activoblog.com/profile